Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thyroid Cancer, Papillary × Famotidine × 1 year × Clear all

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 2 Breast Neoplasms 2 Vomiting 1 Triple Negative Breast Neoplasms 1 Solitary Fibrous Tumors 1 Sarcoma 1 Postoperative Nausea and Vomiting 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Liposarcoma 1 Leukemia, Hairy Cell 1 Histiocytoma, Malignant Fibrous 1 Dermatofibrosarcoma 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Breast Carcinoma In Situ 1

Interventions

Vemurafenib 4 selpercatinib 3 Magnetic Resonance Spectroscopy 3 trametinib 2 entrectinib 2 dabrafenib 2 cobimetinib 2 X-Rays 2 Specimen Handling 2 tremelimumab 1 tovorafenib 1 spartalizumab 1 pralsetinib 1 pembrolizumab 1 lenvatinib 1 gallium Ga 68 dotatate 1 durvalumab 1 copanlisib 1 cabozantinib 1 Whole Body Imaging 1 Thyrotropin Alfa 1 Surveys and Questionnaires 1 Sunitinib 1 Robotic Surgical Procedures 1 Radiofrequency Ablation 1 Postoperative Period 1 Pharmacogenomic Testing 1 Phantoms, Imaging 1 Mitoxantrone 1 Iodine-131 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡